Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis.

about

Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q55208303

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Chloroquine and hydroxychloroq ...... atic review and meta-analysis.

@en

Chloroquine and hydroxychloroq ...... atic review and meta-analysis.

@nl

type

Item

label

Chloroquine and hydroxychloroq ...... atic review and meta-analysis.

@en

Chloroquine and hydroxychloroq ...... atic review and meta-analysis.

@nl

prefLabel

Chloroquine and hydroxychloroq ...... atic review and meta-analysis.

@en

Chloroquine and hydroxychloroq ...... atic review and meta-analysis.

@nl

P1476

Chloroquine and hydroxychloroq ...... atic review and meta-analysis.

@en

P2093

Chang Xu

http://www.w3.org/2001/XMLSchema#string

Dan Liu

http://www.w3.org/2001/XMLSchema#string

Haoming Tian

http://www.w3.org/2001/XMLSchema#string

Qianrui Li

http://www.w3.org/2001/XMLSchema#string

Sheyu Li

http://www.w3.org/2001/XMLSchema#string

Xiaodan Li

http://www.w3.org/2001/XMLSchema#string

Xin Sun

http://www.w3.org/2001/XMLSchema#string

Yiyi Zhang

http://www.w3.org/2001/XMLSchema#string

Yonggang Zhang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

10-year follow-up of intensive glucose control in type 2 diabetes

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.

Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.

The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study.

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

P304

1685-1695

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.2147/DDDT.S166893

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joey Kwong

Ling Li

P5008

ScienceSource

P577

2018-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29928112

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

hydroxychloroquine

chloroquine

P932

6001837

http://www.w3.org/2001/XMLSchema#string